Activity of caspase-6 that cleaves tau at amino acids 402 and 13 was detected in mild to severe AD cases [55], particularly in the entorhinal cortex in absence of plaques and tangles, indicating that it is activated as an initial site affected in AD, resulting in neurodegen-eration and inflammation. This evidence concerns the gene MAPT and Alzheimer disease.